Cannabinoids, the active components of Cannabis sativa, have been shown to exert antiproliferative and proapoptotic effects on a wide spectrum of tumor cells and tissues. Of interest, cannabinoids have displayed great potency in reducing the growth of glioma tumors, one of the most aggressive CNS tumors, either in vitro or in animal experimental models curbing the growth of xenografts generated by subcutaneous or intrathecal injection of glioma cells in immune-deficient mice. Cannabinoids appear to be selective antitumoral agents as they kill glioma cells without affecting the viability of non-transformed cells. This review will summarize the anti-cancer properties that cannabinoids exert on gliomas and discuss their potential action mechan...
Malignant gliomas are the most common primary brain tumors characterized by a high ability to invade...
Cannabinoids are a family of heterogeneous compounds that mostly interact with receptors eliciting s...
Belinda J Cridge, Rhonda J Rosengren Department of Pharmacology and Toxicology, University of Otago,...
Cannabinoids, the active components of Cannabis sativa, have been shown to exert antiproliferative a...
Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer ...
Gliomas constitute the most frequent and malignant primary brain tumors. Current standard therapeuti...
Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoacti...
The current treatment of glioblastoma is not sufficient, since they are heterogeneous and often resi...
Cancer, as a mysterious and complex disease, has a multi-stage molecular process that uses the cellu...
Deni GalileoBecause of the highly invasive nature of brain cancer glioblastoma multiforme (GBM), the...
Cannabinoids bind to two G-protein-coupled receptors, CB1 and CB2, expressed by neurons and cells of...
We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by c...
The efficacy of chemotherapy depends on the tumor microenvironment. This microenvironment consists o...
Background: Cannabinoid receptors have been detected in human gliomas and cannabinoids have been pro...
In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasivenes...
Malignant gliomas are the most common primary brain tumors characterized by a high ability to invade...
Cannabinoids are a family of heterogeneous compounds that mostly interact with receptors eliciting s...
Belinda J Cridge, Rhonda J Rosengren Department of Pharmacology and Toxicology, University of Otago,...
Cannabinoids, the active components of Cannabis sativa, have been shown to exert antiproliferative a...
Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of solid cancer ...
Gliomas constitute the most frequent and malignant primary brain tumors. Current standard therapeuti...
Recently, cannabinoids (CBs) have been shown to possess antitumor properties. Because the psychoacti...
The current treatment of glioblastoma is not sufficient, since they are heterogeneous and often resi...
Cancer, as a mysterious and complex disease, has a multi-stage molecular process that uses the cellu...
Deni GalileoBecause of the highly invasive nature of brain cancer glioblastoma multiforme (GBM), the...
Cannabinoids bind to two G-protein-coupled receptors, CB1 and CB2, expressed by neurons and cells of...
We evaluated the ability of cannabidiol (CBD) to impair the migration of tumor cells stimulated by c...
The efficacy of chemotherapy depends on the tumor microenvironment. This microenvironment consists o...
Background: Cannabinoid receptors have been detected in human gliomas and cannabinoids have been pro...
In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasivenes...
Malignant gliomas are the most common primary brain tumors characterized by a high ability to invade...
Cannabinoids are a family of heterogeneous compounds that mostly interact with receptors eliciting s...
Belinda J Cridge, Rhonda J Rosengren Department of Pharmacology and Toxicology, University of Otago,...